Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2010

Nov 19, 2010

30786_dirs_2010-11-18_64d88ab2-c63f-41fb-be49-48276226f3e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2010-11-18

Reporting Person: TSINGOS CHRISTINE A (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-18 Bio-Rad A Common Stock M 5000 $57.49 Acquired 8335.0979 Direct
2010-11-18 Bio-Rad A Common Stock M 4000 $62.47 Acquired 12335.0979 Direct
2010-11-18 Bio-Rad A Common Stock S 9000 $95.0291 Disposed 3335.0979 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-18 Incentive Stock Option (right to buy) $57.49 M 1617 Disposed 2015-02-09 Bio-Rad A Common Stock (1617) Direct
2010-11-18 Non-Qualified Stock Option (right to buy) $57.49 M 3383 Disposed 2015-02-09 Bio-Rad A Common Stock (3383) Direct
2010-11-18 Incentive Stock Option (right to buy) $62.47 M 680 Disposed 2016-04-03 Bio-Rad A Common Stock (680) Direct
2010-11-18 Non-Qualified Stock Option (right to buy) $62.47 M 3320 Disposed 2016-04-03 Bio-Rad A Common Stock (3320) Direct

Footnotes

F1: Includes 99.0544 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on September 30, 2010.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.96 to $95.13. The reporting person undertakes to provide to Bio-Rad Laboratories, any security holder of Bio-Rad Laboratiores, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The stock option, granted on February 9, 2005, vested over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option, granted on April 3, 2006, vests over five years at 20% per year on the yearly anniversary date of the grant.